US equities
|
MU
$1,039.71
▼-4.44%
NVDA
$231.94
▼-2.33%
SNDK
$1,597.13
▼-5.63%
AMD
$623.24
▼-3.50%
INTC
$106.54
▼-5.82%
SPCX
$161.20
▼-3.82%
PLTR
$197.74
▲+1.87%
META
$713.94
▼-1.02%
MU
$1,039.71
▼-4.44%
NVDA
$231.94
▼-2.33%
SNDK
$1,597.13
▼-5.63%
AMD
$623.24
▼-3.50%
INTC
$106.54
▼-5.82%
SPCX
$161.20
▼-3.82%
PLTR
$197.74
▲+1.87%
META
$713.94
▼-1.02%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Latest News about Veklury
Recent news which mentions Veklury
Gilead Sciences: WHO Expands Recommendation for Veklury® (Remdesivir) to Patients With Severe Disease in Latest Update to COVID-19 Guideline
September 28, 2022
Tickers
GILD
Tags
WHO
Veklury
Gilead Sciences
From
3BL Media: Corporate Social Responsibility, Energy and Health News